申请人:Skerratt Sarah Elizabeth
公开号:US20100256109A1
公开(公告)日:2010-10-07
The present invention relates to a class of EP2 antagonistazetidines of general formula (I), wherein the variables and substituents are as defined herein, and especially to EP2 antagonist compounds, to their use in medicine, particularly in the treatment of endometriosis and/or uterine fibroids (leiomyomata) and to intermediates usefulin their synthesis and to compositions containing them.
本发明涉及一类EP2拮抗剂氮杂环丙烷,其通式为(I),其中变量和取代基的定义如本文所述,特别是EP2拮抗剂化合物,它们在医学上的用途,特别是在治疗子宫内膜异位症和/或子宫肌瘤(平滑肌瘤)方面的用途,以及在其合成过程中有用的中间体和含有它们的组合物。